Vaccination With Flt3L, Radiation, and Poly-ICLC
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Non-Hodgkin's Lymphoma|Metastatic Breast Cancer|Head and Neck Squamous Cell Carcinoma
Interventions: DRUG: Pembrolizumab|DRUG: Flt3L|RADIATION: Radiation|DRUG: Poly ICLC
Sponsor: Icahn School of Medicine at Mount Sinai
Collaborators: Merck Sharp & Dohme LLC|Celldex Therapeutics